BioScrip (BIOS) Misses Q2 EPS by 5c

BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $232.5 million versus the consensus estimate of $229.58 million.

GUIDANCE:

BioScrip sees FY2016 EPS of ($0.48)-($0.38).

For earnings history and earnings-related data on BioScrip (BIOS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• SanDisk upgraded at JPMorgan after investor day; shares climb